Rare variant in scavenger receptor BI raises HDL cholesterol and increases risk of coronary heart disease.

Science
Authors
Keywords
Abstract

Scavenger receptor BI (SR-BI) is the major receptor for high-density lipoprotein (HDL) cholesterol (HDL-C). In humans, high amounts of HDL-C in plasma are associated with a lower risk of coronary heart disease (CHD). Mice that have depleted Scarb1 (SR-BI knockout mice) have markedly elevated HDL-C levels but, paradoxically, increased atherosclerosis. The impact of SR-BI on HDL metabolism and CHD risk in humans remains unclear. Through targeted sequencing of coding regions of lipid-modifying genes in 328 individuals with extremely high plasma HDL-C levels, we identified a homozygote for a loss-of-function variant, in which leucine replaces proline 376 (P376L), in SCARB1, the gene encoding SR-BI. The P376L variant impairs posttranslational processing of SR-BI and abrogates selective HDL cholesterol uptake in transfected cells, in hepatocyte-like cells derived from induced pluripotent stem cells from the homozygous subject, and in mice. Large population-based studies revealed that subjects who are heterozygous carriers of the P376L variant have significantly increased levels of plasma HDL-C. P376L carriers have a profound HDL-related phenotype and an increased risk of CHD (odds ratio = 1.79, which is statistically significant).

Year of Publication
2016
Journal
Science
Volume
351
Issue
6278
Pages
1166-71
Date Published
2016 Mar 11
ISSN
1095-9203
URL
DOI
10.1126/science.aad3517
PubMed ID
26965621
PubMed Central ID
PMC4889017
Links
Grant list
TL1RR024133 / RR / NCRR NIH HHS / United States
TL1R000138 / PHS HHS / United States
R21 DA040177 / DA / NIDA NIH HHS / United States
T32 GM007170 / GM / NIGMS NIH HHS / United States
R01 HG008983 / HG / NHGRI NIH HHS / United States
G0401527 / Medical Research Council / United Kingdom
TL1 RR024133 / RR / NCRR NIH HHS / United States
R01 DK089256 / DK / NIDDK NIH HHS / United States
MR/K013351/1 / Medical Research Council / United Kingdom
PG/08/094/26019 / British Heart Foundation / United Kingdom
G0801566 / Medical Research Council / United Kingdom
RG/14/5/30893 / British Heart Foundation / United Kingdom
R01 HL117078 / HL / NHLBI NIH HHS / United States